| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tachycardia, Ventricular | 13 | 2023 | 239 | 4.260 |
Why?
|
| Arrhythmias, Cardiac | 20 | 2024 | 473 | 3.790 |
Why?
|
| Defibrillators, Implantable | 8 | 2023 | 221 | 2.370 |
Why?
|
| Anti-Arrhythmia Agents | 18 | 2023 | 226 | 1.950 |
Why?
|
| Tachycardia, Supraventricular | 7 | 2022 | 84 | 1.730 |
Why?
|
| Heart Arrest | 4 | 2022 | 358 | 1.670 |
Why?
|
| Death, Sudden, Cardiac | 8 | 2022 | 253 | 1.390 |
Why?
|
| Long QT Syndrome | 5 | 2020 | 92 | 1.370 |
Why?
|
| Exercise Test | 4 | 2019 | 312 | 1.340 |
Why?
|
| Atrial Fibrillation | 4 | 2023 | 719 | 1.290 |
Why?
|
| Electrocardiography | 20 | 2021 | 1145 | 1.280 |
Why?
|
| Wolff-Parkinson-White Syndrome | 4 | 2022 | 62 | 1.280 |
Why?
|
| Heart Defects, Congenital | 13 | 2023 | 1697 | 1.200 |
Why?
|
| Cardiomyopathies | 4 | 2022 | 610 | 1.120 |
Why?
|
| Vitamin B Complex | 2 | 2023 | 51 | 1.120 |
Why?
|
| Cardiomyopathy, Hypertrophic | 7 | 2021 | 192 | 1.090 |
Why?
|
| Echocardiography | 9 | 2021 | 1182 | 1.070 |
Why?
|
| Sotalol | 5 | 2023 | 31 | 1.010 |
Why?
|
| Child | 47 | 2022 | 29154 | 0.820 |
Why?
|
| Exosome Multienzyme Ribonuclease Complex | 1 | 2021 | 8 | 0.810 |
Why?
|
| Heart Rate | 6 | 2022 | 737 | 0.800 |
Why?
|
| Heart Conduction System | 4 | 2017 | 165 | 0.790 |
Why?
|
| Ataxia | 1 | 2022 | 176 | 0.790 |
Why?
|
| Pacemaker, Artificial | 5 | 2016 | 213 | 0.740 |
Why?
|
| Coronary Aneurysm | 1 | 2019 | 36 | 0.700 |
Why?
|
| Cardiology | 7 | 2021 | 530 | 0.700 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 107 | 0.680 |
Why?
|
| Catheter Ablation | 8 | 2022 | 620 | 0.670 |
Why?
|
| Child, Preschool | 27 | 2022 | 16273 | 0.670 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2019 | 76 | 0.660 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 305 | 0.660 |
Why?
|
| Infant | 26 | 2022 | 13310 | 0.650 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 5 | 2024 | 69 | 0.640 |
Why?
|
| Genetic Association Studies | 3 | 2021 | 1084 | 0.630 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2018 | 244 | 0.610 |
Why?
|
| Adolescent | 34 | 2023 | 31252 | 0.590 |
Why?
|
| Seizures | 1 | 2022 | 989 | 0.580 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 2 | 2022 | 24 | 0.530 |
Why?
|
| Sick Sinus Syndrome | 1 | 2015 | 14 | 0.530 |
Why?
|
| Retrospective Studies | 37 | 2022 | 37905 | 0.530 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2015 | 36 | 0.530 |
Why?
|
| Syncope | 1 | 2015 | 64 | 0.520 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2016 | 69 | 0.520 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 984 | 0.520 |
Why?
|
| Circadian Rhythm | 1 | 2017 | 330 | 0.520 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2021 | 5539 | 0.500 |
Why?
|
| Phenotype | 6 | 2022 | 6295 | 0.490 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 1506 | 0.490 |
Why?
|
| Electric Countershock | 4 | 2021 | 71 | 0.490 |
Why?
|
| Heart Failure | 4 | 2022 | 2516 | 0.480 |
Why?
|
| Atrioventricular Block | 4 | 2021 | 36 | 0.470 |
Why?
|
| Flecainide | 3 | 2021 | 27 | 0.460 |
Why?
|
| Sudden Infant Death | 1 | 2013 | 33 | 0.460 |
Why?
|
| Humans | 78 | 2023 | 261506 | 0.450 |
Why?
|
| Propranolol | 3 | 2022 | 156 | 0.450 |
Why?
|
| Ventricular Fibrillation | 1 | 2013 | 61 | 0.440 |
Why?
|
| Body Surface Potential Mapping | 2 | 2012 | 14 | 0.420 |
Why?
|
| Mutation | 7 | 2021 | 15179 | 0.410 |
Why?
|
| Cardiac Pacing, Artificial | 4 | 2020 | 127 | 0.400 |
Why?
|
| Myocarditis | 1 | 2013 | 190 | 0.400 |
Why?
|
| Fluoroscopy | 2 | 2013 | 232 | 0.380 |
Why?
|
| Male | 46 | 2022 | 123000 | 0.380 |
Why?
|
| Ventricular Function, Left | 2 | 2016 | 603 | 0.380 |
Why?
|
| Female | 47 | 2023 | 141928 | 0.380 |
Why?
|
| Cardiac Imaging Techniques | 2 | 2020 | 46 | 0.380 |
Why?
|
| Heart | 3 | 2015 | 1223 | 0.370 |
Why?
|
| Hospitalization | 4 | 2022 | 2083 | 0.360 |
Why?
|
| Patient Care Management | 2 | 2020 | 94 | 0.360 |
Why?
|
| Radiation Dosage | 2 | 2013 | 1014 | 0.360 |
Why?
|
| Infant, Newborn | 15 | 2021 | 8223 | 0.350 |
Why?
|
| Follow-Up Studies | 13 | 2019 | 14889 | 0.350 |
Why?
|
| Heart Neoplasms | 1 | 2011 | 214 | 0.340 |
Why?
|
| Tachycardia, Ectopic Atrial | 1 | 2008 | 6 | 0.330 |
Why?
|
| Inpatients | 1 | 2013 | 678 | 0.320 |
Why?
|
| Rheumatic Fever | 1 | 2007 | 18 | 0.310 |
Why?
|
| Treatment Outcome | 20 | 2023 | 32848 | 0.310 |
Why?
|
| Endosonography | 1 | 2010 | 536 | 0.300 |
Why?
|
| Exome | 4 | 2022 | 1239 | 0.290 |
Why?
|
| Risk Factors | 13 | 2022 | 17523 | 0.290 |
Why?
|
| American Heart Association | 5 | 2020 | 310 | 0.280 |
Why?
|
| United States | 17 | 2021 | 15433 | 0.280 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2020 | 133 | 0.280 |
Why?
|
| Young Adult | 14 | 2021 | 21445 | 0.280 |
Why?
|
| Heart Atria | 3 | 2024 | 352 | 0.270 |
Why?
|
| Incidence | 9 | 2021 | 5673 | 0.270 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2017 | 164 | 0.260 |
Why?
|
| Cardiac Electrophysiology | 2 | 2016 | 10 | 0.260 |
Why?
|
| Predictive Value of Tests | 7 | 2020 | 4892 | 0.260 |
Why?
|
| Tertiary Care Centers | 2 | 2017 | 403 | 0.230 |
Why?
|
| Texas | 7 | 2019 | 6311 | 0.230 |
Why?
|
| Gene Deletion | 3 | 2018 | 1442 | 0.230 |
Why?
|
| Heart Block | 1 | 2022 | 48 | 0.220 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2022 | 15 | 0.220 |
Why?
|
| Verapamil | 1 | 2022 | 78 | 0.210 |
Why?
|
| Medicine | 2 | 2022 | 137 | 0.210 |
Why?
|
| Mass Screening | 3 | 2017 | 1509 | 0.210 |
Why?
|
| Hospital Mortality | 3 | 2022 | 1274 | 0.210 |
Why?
|
| Isoproterenol | 1 | 2022 | 127 | 0.210 |
Why?
|
| Tachycardia, Ectopic Junctional | 1 | 2021 | 10 | 0.210 |
Why?
|
| Siblings | 1 | 2023 | 285 | 0.210 |
Why?
|
| Vitamins | 1 | 2022 | 157 | 0.210 |
Why?
|
| Administration, Intravenous | 2 | 2023 | 249 | 0.200 |
Why?
|
| Magnesium | 1 | 2022 | 160 | 0.200 |
Why?
|
| Amiodarone | 1 | 2021 | 42 | 0.200 |
Why?
|
| Pedigree | 3 | 2021 | 1890 | 0.200 |
Why?
|
| Hypnotics and Sedatives | 2 | 2013 | 218 | 0.200 |
Why?
|
| Canada | 4 | 2019 | 429 | 0.200 |
Why?
|
| Education, Distance | 1 | 2022 | 93 | 0.200 |
Why?
|
| Statistics, Nonparametric | 3 | 2016 | 980 | 0.190 |
Why?
|
| Facies | 1 | 2021 | 149 | 0.190 |
Why?
|
| Sequence Analysis, DNA | 2 | 2021 | 2483 | 0.190 |
Why?
|
| Heart Ventricles | 4 | 2024 | 846 | 0.190 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 2018 | 66 | 0.190 |
Why?
|
| Prenatal Care | 1 | 2022 | 325 | 0.180 |
Why?
|
| Risk Assessment | 6 | 2021 | 6869 | 0.180 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2016 | 300 | 0.180 |
Why?
|
| Time Factors | 10 | 2022 | 12926 | 0.180 |
Why?
|
| Adenosine | 1 | 2022 | 289 | 0.180 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2019 | 44 | 0.170 |
Why?
|
| Genotype | 3 | 2023 | 4109 | 0.170 |
Why?
|
| Consensus | 3 | 2020 | 978 | 0.170 |
Why?
|
| Myopathies, Nemaline | 1 | 2018 | 9 | 0.170 |
Why?
|
| Dietary Supplements | 1 | 2023 | 558 | 0.170 |
Why?
|
| Secondary Prevention | 1 | 2021 | 329 | 0.170 |
Why?
|
| Aftercare | 1 | 2020 | 259 | 0.170 |
Why?
|
| Primary Prevention | 1 | 2021 | 255 | 0.170 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 3 | 2017 | 244 | 0.170 |
Why?
|
| Ebstein Anomaly | 1 | 2018 | 20 | 0.160 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2013 | 1237 | 0.160 |
Why?
|
| Desmoplakins | 1 | 2017 | 22 | 0.160 |
Why?
|
| Keratosis | 1 | 2017 | 39 | 0.160 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2017 | 29 | 0.150 |
Why?
|
| Prosthesis Failure | 1 | 2019 | 206 | 0.150 |
Why?
|
| Catecholamines | 1 | 2017 | 101 | 0.150 |
Why?
|
| Survival Rate | 6 | 2021 | 12221 | 0.150 |
Why?
|
| Heterotaxy Syndrome | 1 | 2017 | 63 | 0.150 |
Why?
|
| Sleep Deprivation | 1 | 2017 | 51 | 0.150 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 413 | 0.150 |
Why?
|
| Cognition | 1 | 2023 | 968 | 0.150 |
Why?
|
| Postoperative Complications | 5 | 2020 | 5542 | 0.150 |
Why?
|
| Troponin T | 1 | 2018 | 261 | 0.150 |
Why?
|
| Anticoagulants | 1 | 2022 | 787 | 0.140 |
Why?
|
| Athletes | 1 | 2017 | 73 | 0.140 |
Why?
|
| Syndactyly | 1 | 2016 | 26 | 0.140 |
Why?
|
| Azithromycin | 1 | 2016 | 78 | 0.140 |
Why?
|
| Prospective Studies | 5 | 2022 | 12873 | 0.140 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2020 | 435 | 0.140 |
Why?
|
| Plasma Membrane Calcium-Transporting ATPases | 1 | 2015 | 4 | 0.140 |
Why?
|
| Tilt-Table Test | 1 | 2015 | 8 | 0.140 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2016 | 88 | 0.140 |
Why?
|
| Calcium Channels, L-Type | 1 | 2016 | 76 | 0.140 |
Why?
|
| Rhabdomyolysis | 1 | 2016 | 52 | 0.130 |
Why?
|
| Acute Disease | 2 | 2013 | 2422 | 0.130 |
Why?
|
| Pulmonary Valve | 1 | 2016 | 87 | 0.130 |
Why?
|
| Hospitals, Pediatric | 2 | 2017 | 773 | 0.130 |
Why?
|
| Muscle Weakness | 1 | 2016 | 116 | 0.130 |
Why?
|
| Cohort Studies | 6 | 2020 | 9244 | 0.130 |
Why?
|
| Evidence-Based Medicine | 4 | 2020 | 1085 | 0.130 |
Why?
|
| Weightlessness Simulation | 1 | 2014 | 24 | 0.130 |
Why?
|
| Amino Acids | 1 | 2018 | 728 | 0.130 |
Why?
|
| Models, Cardiovascular | 1 | 2015 | 202 | 0.130 |
Why?
|
| Tachycardia, Reciprocating | 1 | 2014 | 1 | 0.130 |
Why?
|
| Age Factors | 5 | 2019 | 5377 | 0.120 |
Why?
|
| Digoxin | 1 | 2014 | 63 | 0.120 |
Why?
|
| Sports | 2 | 2013 | 80 | 0.120 |
Why?
|
| Community-Acquired Infections | 1 | 2016 | 285 | 0.120 |
Why?
|
| Genetic Variation | 3 | 2018 | 2086 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2013 | 1270 | 0.120 |
Why?
|
| Pediatrics | 2 | 2014 | 1141 | 0.120 |
Why?
|
| Quality of Life | 2 | 2022 | 4532 | 0.120 |
Why?
|
| Brugada Syndrome | 1 | 2014 | 18 | 0.120 |
Why?
|
| Stroke Volume | 2 | 2013 | 577 | 0.120 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2014 | 234 | 0.120 |
Why?
|
| Stroke | 1 | 2022 | 1144 | 0.120 |
Why?
|
| Sympathectomy | 1 | 2013 | 14 | 0.120 |
Why?
|
| Prostheses and Implants | 1 | 2016 | 295 | 0.120 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2014 | 177 | 0.110 |
Why?
|
| Anesthetics, Dissociative | 1 | 2013 | 22 | 0.110 |
Why?
|
| Autistic Disorder | 1 | 2016 | 319 | 0.110 |
Why?
|
| Electrophysiological Phenomena | 1 | 2013 | 75 | 0.110 |
Why?
|
| Australia | 1 | 2013 | 225 | 0.110 |
Why?
|
| Electrophysiology | 1 | 2013 | 333 | 0.110 |
Why?
|
| Myocytes, Cardiac | 2 | 2017 | 764 | 0.110 |
Why?
|
| Algorithms | 3 | 2020 | 3890 | 0.110 |
Why?
|
| Cryosurgery | 1 | 2014 | 167 | 0.110 |
Why?
|
| Pulmonary Artery | 1 | 2016 | 499 | 0.110 |
Why?
|
| Databases as Topic | 2 | 2014 | 133 | 0.110 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2012 | 36 | 0.110 |
Why?
|
| Shock, Cardiogenic | 1 | 2014 | 228 | 0.110 |
Why?
|
| Pre-Excitation Syndromes | 1 | 2011 | 3 | 0.110 |
Why?
|
| Genetic Testing | 2 | 2018 | 1589 | 0.100 |
Why?
|
| Dexmedetomidine | 1 | 2013 | 85 | 0.100 |
Why?
|
| Electroencephalography | 1 | 2016 | 898 | 0.100 |
Why?
|
| Rhabdomyoma | 1 | 2011 | 23 | 0.100 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2012 | 74 | 0.100 |
Why?
|
| Coronary Vessels | 1 | 2016 | 665 | 0.100 |
Why?
|
| Ventricular Function, Right | 1 | 2012 | 111 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2013 | 756 | 0.100 |
Why?
|
| Sex Distribution | 2 | 2016 | 495 | 0.100 |
Why?
|
| Myxoma | 1 | 2011 | 63 | 0.100 |
Why?
|
| Calcium | 2 | 2014 | 1537 | 0.100 |
Why?
|
| Fibroma | 1 | 2011 | 85 | 0.100 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2013 | 255 | 0.100 |
Why?
|
| Radiography, Interventional | 1 | 2013 | 305 | 0.100 |
Why?
|
| Age Distribution | 2 | 2016 | 698 | 0.100 |
Why?
|
| Sinus of Valsalva | 1 | 2011 | 53 | 0.100 |
Why?
|
| Accessory Atrioventricular Bundle | 1 | 2010 | 7 | 0.100 |
Why?
|
| Adult | 10 | 2020 | 77950 | 0.100 |
Why?
|
| Pericardium | 1 | 2012 | 157 | 0.090 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2016 | 563 | 0.090 |
Why?
|
| Risk Adjustment | 2 | 2020 | 83 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 4938 | 0.090 |
Why?
|
| Atrial Appendage | 1 | 2010 | 55 | 0.090 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2012 | 218 | 0.090 |
Why?
|
| Pregnancy | 1 | 2022 | 7573 | 0.090 |
Why?
|
| DNA | 1 | 2018 | 2693 | 0.090 |
Why?
|
| Societies, Medical | 1 | 2016 | 1335 | 0.090 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1148 | 0.090 |
Why?
|
| Ketamine | 1 | 2013 | 234 | 0.090 |
Why?
|
| Patient Compliance | 1 | 2013 | 667 | 0.080 |
Why?
|
| Recurrence | 2 | 2014 | 4758 | 0.080 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2014 | 581 | 0.080 |
Why?
|
| Fetal Diseases | 1 | 2011 | 388 | 0.080 |
Why?
|
| Chorea | 1 | 2007 | 34 | 0.080 |
Why?
|
| Patient Selection | 3 | 2020 | 2055 | 0.070 |
Why?
|
| Seasons | 1 | 2007 | 340 | 0.070 |
Why?
|
| Insurance, Health | 1 | 2007 | 250 | 0.070 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 622 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 2195 | 0.070 |
Why?
|
| Homozygote | 2 | 2018 | 717 | 0.060 |
Why?
|
| Age of Onset | 2 | 2017 | 827 | 0.060 |
Why?
|
| Heart-Assist Devices | 1 | 2014 | 1171 | 0.060 |
Why?
|
| Exons | 2 | 2018 | 1328 | 0.060 |
Why?
|
| Device Removal | 2 | 2019 | 337 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 4298 | 0.050 |
Why?
|
| Vitamin K | 1 | 2022 | 54 | 0.050 |
Why?
|
| Electric Stimulation | 1 | 2024 | 426 | 0.050 |
Why?
|
| Vitamin A | 1 | 2022 | 94 | 0.050 |
Why?
|
| California | 2 | 2013 | 208 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 8865 | 0.050 |
Why?
|
| DNA Mutational Analysis | 2 | 2018 | 2283 | 0.050 |
Why?
|
| Parents | 2 | 2022 | 998 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 4744 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2017 | 1945 | 0.050 |
Why?
|
| Cardiac Catheterization | 2 | 2017 | 687 | 0.050 |
Why?
|
| LIM Domain Proteins | 1 | 2020 | 104 | 0.050 |
Why?
|
| Prognosis | 2 | 2017 | 21713 | 0.040 |
Why?
|
| Mice | 5 | 2024 | 34495 | 0.040 |
Why?
|
| Czech Republic | 1 | 2019 | 14 | 0.040 |
Why?
|
| Ankyrins | 1 | 2020 | 104 | 0.040 |
Why?
|
| Base Sequence | 2 | 2016 | 4917 | 0.040 |
Why?
|
| Middle Aged | 5 | 2018 | 86204 | 0.040 |
Why?
|
| Self Report | 1 | 2022 | 756 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2020 | 492 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 485 | 0.040 |
Why?
|
| Calsequestrin | 1 | 2017 | 12 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2017 | 5637 | 0.040 |
Why?
|
| Comorbidity | 2 | 2016 | 2352 | 0.040 |
Why?
|
| Health Personnel | 1 | 2022 | 625 | 0.040 |
Why?
|
| Telemetry | 1 | 2016 | 39 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2017 | 241 | 0.040 |
Why?
|
| Antigens | 1 | 2017 | 292 | 0.040 |
Why?
|
| Fetus | 1 | 2020 | 601 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2017 | 259 | 0.040 |
Why?
|
| Penicillins | 1 | 2016 | 143 | 0.030 |
Why?
|
| Arabs | 1 | 2016 | 38 | 0.030 |
Why?
|
| Cephalosporins | 1 | 2016 | 148 | 0.030 |
Why?
|
| Animals | 5 | 2024 | 59536 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2019 | 749 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2020 | 661 | 0.030 |
Why?
|
| Heart Diseases | 2 | 2012 | 732 | 0.030 |
Why?
|
| Causality | 1 | 2016 | 178 | 0.030 |
Why?
|
| Pneumonia, Bacterial | 1 | 2016 | 130 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2022 | 5687 | 0.030 |
Why?
|
| Sodium Channels | 1 | 2015 | 109 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 2016 | 147 | 0.030 |
Why?
|
| Hindlimb Suspension | 1 | 2014 | 13 | 0.030 |
Why?
|
| International Cooperation | 1 | 2016 | 323 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2020 | 1143 | 0.030 |
Why?
|
| Rabbits | 1 | 2015 | 957 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2015 | 406 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 204 | 0.030 |
Why?
|
| Syndrome | 1 | 2017 | 1351 | 0.030 |
Why?
|
| Europe | 1 | 2016 | 649 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2017 | 974 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2017 | 1163 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2014 | 1303 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2014 | 191 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2017 | 745 | 0.030 |
Why?
|
| Boston | 1 | 2013 | 108 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2014 | 184 | 0.030 |
Why?
|
| Punctures | 1 | 2013 | 104 | 0.030 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2016 | 318 | 0.030 |
Why?
|
| Internationality | 1 | 2014 | 208 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2014 | 248 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2014 | 430 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2015 | 1471 | 0.030 |
Why?
|
| Echocardiography, Doppler | 1 | 2012 | 180 | 0.030 |
Why?
|
| Genomics | 1 | 2022 | 2738 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2020 | 2022 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 2012 | 183 | 0.020 |
Why?
|
| Patient Safety | 1 | 2017 | 649 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2017 | 899 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 1270 | 0.020 |
Why?
|
| Self Concept | 1 | 2012 | 211 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2011 | 275 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2016 | 1152 | 0.020 |
Why?
|
| Myocardial Revascularization | 1 | 2011 | 134 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2011 | 355 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2014 | 1338 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2012 | 305 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2017 | 2803 | 0.020 |
Why?
|
| Dissection | 1 | 2010 | 156 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 2437 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2016 | 2218 | 0.020 |
Why?
|
| Anesthesia | 1 | 2013 | 296 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 2139 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 1323 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2016 | 6089 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 1293 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2012 | 672 | 0.020 |
Why?
|
| Equipment Design | 1 | 2012 | 1204 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 2450 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 4971 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 2011 | 435 | 0.020 |
Why?
|
| Genome, Human | 1 | 2015 | 1869 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 4821 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 2316 | 0.020 |
Why?
|
| Reoperation | 1 | 2011 | 1382 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2011 | 509 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 4804 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 4320 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 2011 | 462 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 6009 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2020 | 5270 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 6086 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2016 | 9180 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 5710 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 3441 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2011 | 908 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 6942 | 0.010 |
Why?
|
| Aged | 2 | 2021 | 70117 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 4314 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 7222 | 0.010 |
Why?
|
| Biomarkers | 1 | 2012 | 5047 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 29902 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 11965 | 0.010 |
Why?
|